Last reviewed · How we verify
NCT05689632
Vitamins D and K Effects on Vascular Function in Obese Adults.
NA trial testing Vitamin D3 + K2-MK7 in Obesity in 100 participants. Status unknown.
15 July 2023
Quick facts
| Lead sponsor | Hospital Universitario Pedro Ernesto |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 15 July 2022 |
| Primary completion | 15 July 2023 |
| Estimated completion | 15 November 2023 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Vitamin D3 + K2-MK7
- Placebo
- Vitamin D3 (cholecalciferol) — full drug profile →
Conditions studied
- Obesity — all drugs for Obesity →
- Vitamin D3 Deficiency — all drugs for Vitamin D3 Deficiency →
Sponsor
Hospital Universitario Pedro Ernesto
Who can join
Adults 40 to 70, any sex, with Obesity or Vitamin D3 Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, randomized, placebo-controlled, double-blind study that aims to evaluate the effects of combined vitamin D3 and K2-MK7 supplementation on vascular function, sympathetic tone, metabolic biomarkers and inflammatory factors in a population of overweight or obese adults and deficient or insufficient serum levels of vitamin D.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05689632
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Hospital Universitario Pedro Ernesto trials
Trials by the same sponsor.
- NCT07511738 — Testing the Youth Physical Activity Promotion Model (YPAP) in Brazilian Adolescents · not yet recruiting
- NCT07276243 — Polidocanol Foam With or Without Transdermal Laser for Varicose Veins: Randomized Clinical Trial · NA · not yet recruiting
- NCT06664645 — Rotator Cuff Tears Treated With Long Head of the Biceps Reinforcement · NA · completed
- NCT04020796 — Acute Effects of Beet Juice Intake on the Vascular Function of Hypertensive Patients · NA · completed
- NCT03503448 — Comparison of 2 Techniques of Surgically Assisted Rapid Maxillary Expansion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05689632 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario Pedro Ernesto
- Last refreshed: 19 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05689632.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing